Page last updated: 2024-11-12

barbamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

barbamide: from the marine Carribean cyanobacterium Lyngbya majuscula; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11465376
CHEBI ID80028
MeSH IDM0263878

Synonyms (5)

Synonym
barbamide
CHEBI:80028
Q27149173
DTXSID901334663
(e,5s)-6,6,6-trichloro-3-methoxy-n,5-dimethyl-n-[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide

Research Excerpts

Overview

Barbamide is a mixed polypeptide-polyketide natural product. It contains an unusual trichloromethyl group.

ExcerptReferenceRelevance
"Barbamide is a mixed polypeptide-polyketide natural product that contains an unusual trichloromethyl group. "( Characterization of the initial enzymatic steps of barbamide biosynthesis.
Flatt, PM; Gerwick, WH; McPhail, KL; O'Connell, SJ; Sherman, DH; Willis, CL; Zeller, G, 2006
)
2.03
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
fatty amideA monocarboxylic acid amide derived from a fatty acid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's1 (7.14)18.2507
2000's6 (42.86)29.6817
2010's4 (28.57)24.3611
2020's2 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.10

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.10 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.10)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]